International Biotechnol... Share Discussion Threads

[maxwellsdemon] 27/5/2002 19:28

21up,

it is probably because the NASDAQ Biotech Index was down 4% on Friday

[21up] 27/5/2002 18:07

1207 SELLS 7070 BUYS,shares go south?

[21up] 23/5/2002 14:23

RAMBUTAN2 Thanks for your info,like many others i'm still learning this share game.

[rambutan2] 22/5/2002 20:16

Exeter seem to have been buying for their various unit/investment trusts, and they have a good track record in buying undervalued trusts, but the co-op is selling down its big stake. Also, one of the directors bought recently. IMOH this will go up 50% with just the slightest pick up in the US bio mkt. Remember, only 3 months ago it was 150p to buy. At this price, on a 20plus% discount its a bargain. Plus, remember that a chunk of the venture cap port is valued at cost and SVLS have a v good track record in the VC field and the ability to get in on all the best deals.

[21up] 22/5/2002 14:46

y's price gone up with 0 buyers?

[21up] 15/4/2002 16:39

And another

[21up] 15/4/2002 16:34

A CUPPLE OF large trades at end of day?

[21up] 11/4/2002 15:20

What's going on with the 2 25000 trades?

[gfarrell] 14/2/2002 23:21

Soon I hope, but I'm also prepared to wait. Biotechs are widely tipped for strong but volatile growth but sentiment is cyclical and there's a shortage of good news at present.

[21up] 14/2/2002 20:33

when is this going to move up?I thought Soros had a stake.

[yiyack3] 28/10/2001 01:04

See
Lists the main investments as;

AnorMED Inc.
Axxima Pharmaceuticals AG
Biocompatibles International plc
CeNeS Pharmaceuticals
Corixa Corporation
Corvas International Inc
Delsys Pharmaceutical Corporation
Entigen
Epimmune Inc
Eyetech Pharmaceuticals
Inflazyme Pharmaceuticals Ltd
Micromet
NetGenics Inc
Onyx Pharmaceuticals
OSI Pharmaceuticals
Ribozyme Pharmaceuticals Inc
Sunesis Pharmaceuticals Inc.
Targeted Genetics Corporation
ValiGen
Vernalis

Has at least 25% invested in unlisted companies.

Also check out 3i Biotechnology (TBS), which tends to invest more in mid/large cap biotech companies, and Finsbury Life (FLS) which is mainly invested in UK companies. They have been more or less tracking each other over the past 6 months while the only significant factor affecting price has been sentiment, but FLS and TBS have risen more rapidly in the past month (influence of larger cap companies).
I think any of these is would be a great investment and all are at wider discounts than normal.

[colinscarr] 27/10/2001 21:58

Any thoughts whether this is an option to buy into with a few of the bio-tech shares shooting up latel ??
Also, where can you check out a list of its investments ?

[jasey3] 21/10/2001 04:31

CHECKOUT EINSTEIN TV ,,EPIC EIC THIS BABYS FLYING

[boxwellian] 14/9/2001 16:00

Nav 203p Share Price 143p

[yiyack3] 11/3/2001 21:16

Management of the the well known International Biotechnology investment trust was taken over resently by Schroders, who have much biotech experience through their venture capital activities. Also, Schroders are heavily promoting their Medical Discovery fund for the ISA season.
There's an article in Sunday Business headed 'Ask what the sell-by date is', about stocks and sectors that fund managers do not like, and which contains the following;

......Justin Abercrombie, who as head of investment strategy at Schroders sets its asset allocation policy, offers a sector to avoid: biotechnology. "The names in there are selling on air" he says, "Eventually people will realise that".....

Whether or not you agree with him, isn't this a pretty shocking attitude and statement for an influential senior guy in a fund management company so heavily into biotechs?

[gfarrell] 28/12/2000 12:08

This is not advice - I think you might get slightly better price from the offer than on the market. That is, if you want to sell - I'm keeping mine long term.

[tonsil] 27/12/2000 23:45

can anyone advise whether to take up the buy back offer or not?

[m.t.glass] 19/12/2000 10:04

The buy-back scheme announced yesterday (forced on management by dissidents) appears to have gone down like a lead balloon. 100% sells so far today and price falling accordingly.

[m.t.glass] 27/11/2000 10:51

Annual Report out today (see RNS/AFX News items) shows a 485% rise in share price during the year, confirming IBT's ranking as number one in the biotech and healthcare sectors in both UK investment trusts and unit trusts over that period. Also number one in the International Smaller Companies sector.

[stultissimus] 11/11/2000 06:08

IBT:- look at the quality of this trust's quoted investments,. Mainly in the US
TGEN;CVAS;ANPI;ONXX;RZYM;OSIP;CTIC; then look at its current discount to NAV.

Most of the listed stocks are in phase II FDA or have fast track status or are in joint collaborative agreements with bigger pharmas. The Bio's they have invested in have been around a while and are a long way down the path of development and now there are several new drugs are close to being released with many others to follow in the pipeline.

With the mapping of the human genome complete and several unquoted investments on the books, at cost, which are active in areas relating to terminal genetic illnesses and cancers, this sector has got to be one of the growth sectors during the next few years.

A few things will increase the share price over the next 12 months.

1) The discount to NAV will reduce as this and other companies in the sector announce new drugs targeted at these killer illnesses.

2) The NAV of the trust will increase as the share price of constituent holdings increases, due to imminent and on going announcements in this sector.

3) The NAV will increase has more IPO's occur from within the trusts holding.

What is the downside?

1) Not all of the investments will get the breakthrough, but with a wide-ranging global portfolio of investments the risk is well spread into several key areas of this technology.

2) Sentiment could turn against the sector if there were to be some bad feedback on drug trials and this in turn reduce the NAV of the trust's holdings. One good announcement of a treatment for an incurable disease would soon eradicate this sentiment.


The question I keep asking myself is would I rather invest in a sector that is close to having a share in many treatments for a life threatening diseases or a technology sector that is reliant on the fads of consumer participation. I think the figure of 1 in 5 people are effected by some form of Cancer brings a sort of perspective of the immensity of the potential of this fast maturing sector

[m.t.glass] 11/11/2000 01:07

Date: 10 Nov 2000 14:34:09
Service: Regulatory News Service
RNS Number:8972T
Intl. Biotechnology Trust PLC
9 November 2000


Letter to: Company Announcements Office

SUBSTANTIAL SHARE INTEREST NOTIFICATION

We are writing to advise you that the Company was notified on 9 November 2000,
that Charlamont Trading Limited, is interested in 3,285,000 ordinary shares of
25p each, representing 3.73% of the 88,002,177 ordinary shares in issue,
following a purchase of 1,000,000 shares on 6 November 2000.

Soros Fund Management LLC acts as principal investment advisor to Quantum
Endowment Fund N.V., the operating subsidiary of which is Quantum Partners LDC.
Charlamont Trading Limited is a 100% trading subsidiary of Quantum Partners and
in consequence Quantum Partners LDC and Quantum Endowment Fund N.V. have also
acquired an interest in the shares. The registered holder of the shares is
Morgan Stanley International Nominees Limited as Custodian for Charlamont
Trading Limited.

Letter from: Schroder Investment Management Ltd.

END
-----------------------------------------------------------------------

This share has risen fivefold in 12 months (closed at 335.5p on 10/11/00, from 66.5p on 12/11/99).

Website is www.internationalbiotrust.com

[ding dong] 17/8/2000 16:32

Bringing this one to the top.
After a strong run over the last few weeks, it seems to be struggling to get through the 300 barrier agin. Lots of sells today and yesterday. One for the shortists in the near future?

[applebypd] 17/7/2000 18:11

SOme people are waiting for a return of capital as promised in the EGM. Others are taking a small profit. I'm hanging in there. (Maybe should have got out at 350 last year or 280 recently)

[mart] 06/7/2000 15:52

I'm feeling quite warm toward these at the moment. Despite the fact that I really bought them too high they are one of the few successes in my portfolio over the last month or so, sob.